Paper41767367
A pilot study on a combined non-invasive screening test for metabolic dysfunction-associated steatotic liver disease and type 2 diabetes.
Saenger K and 5 others. Front Endocrinol (Lausanne), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. A pilot study on a combined non-invasive screening test for metabolic dysfunction-associated steatotic liver disease and type 2 diabetes. Papers, record 41767367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41767367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A pilot study on a combined non-invasive screening test for metabolic dysfunction-associated steatotic liver disease and type 2 diabetes.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Metabolic Diseases | Major topic |
| Fatty Liver | Major topic |
| Humans | |
| Female | |
| Middle Aged | |
| Pilot Projects | |
| Male | |
| Breath Tests | |
| Glucose Tolerance Test | |
| Methionine | |
| Blood Glucose | |
| Aged | |
| Insulin Resistance | |
| Carbon Isotopes |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23663133 | Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives. | Expert Opin Pharmacother | 2013 | https://conductscience.org/library/papers/23663133 | PubMed |
| 2 | 36209983 | Mitochondrial alterations in fatty liver diseases. | J Hepatol | 2023 | https://conductscience.org/library/papers/36209983 | PubMed |
| 3 | 40362504 | Mitochondrial Dysfunction as a Pathogenesis and Therapeutic Strategy for Metabolic-Dysfunction-Associated Steatotic Liver Disease. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362504 | PubMed |
| 4 | 17567829 | FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. | Hepatology | 2007 | https://conductscience.org/library/papers/17567829 | PubMed |
| 5 | 35939943 | Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride/glucose index. | Diabetes Metab Syndr | 2022 | https://conductscience.org/library/papers/35939943 | PubMed |
| 6 | 6852464 | Regulation of the gastric emptying of glucose. | Gastroenterology | 1983 | https://conductscience.org/library/papers/6852464 | PubMed |
| 7 | 26781921 | Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects for the future. | Drug Discov Ther | 2015 | https://conductscience.org/library/papers/26781921 | PubMed |
| 8 | 35183303 | A global view of the interplay between non-alcoholic fatty liver disease and diabetes. | Lancet Diabetes Endocrinol | 2022 | https://conductscience.org/library/papers/35183303 | PubMed |
| 9 | 10912667 | Non-Invasive assessment of human hepatic mitochondrial function through the 13C-methionine breath test. | Scand J Gastroenterol | 2000 | https://conductscience.org/library/papers/10912667 | PubMed |
| 10 | 36051951 | EASL clinical practice guidelines: non-invasive liver tests for evaluation of liver disease severity and prognosis. | Frontline Gastroenterol | 2022 | https://conductscience.org/library/papers/36051951 | PubMed |
| 11 | 31141525 | Glucose metabolism is differentially altered by choline and methionine in bovine neonatal hepatocytes. | PLoS One | 2019 | https://conductscience.org/library/papers/31141525 | PubMed |
| 12 | 12552242 | Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis. | Med Sci Monit | 2003 | https://conductscience.org/library/papers/12552242 | PubMed |
| 13 | 39860434 | The Triad of Risk: Linking MASLD, Cardiovascular Disease and Type 2 Diabetes; From Pathophysiology to Treatment. | J Clin Med | 2025 | https://conductscience.org/library/papers/39860434 | PubMed |
| 14 | 20495833 | The predictive value of TNF-α and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetes. | Acta Diabetol | 2012 | https://conductscience.org/library/papers/20495833 | PubMed |
| 15 | 18513202 | Longitudinal effects of hepatitis C virus treatment on hepatic mitochondrial dysfunction assessed by C-methionine breath test. | Aliment Pharmacol Ther | 2008 | https://conductscience.org/library/papers/18513202 | PubMed |
| 16 | 32946642 | Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review. | Liver Int | 2021 | https://conductscience.org/library/papers/32946642 | PubMed |
| 17 | 17695343 | G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. | Behav Res Methods | 2007 | https://conductscience.org/library/papers/17695343 | PubMed |
| 18 | 23216872 | Comprehensive assessment of gastric emptying with a stable isotope breath test. | Neurogastroenterol Motil | 2013 | https://conductscience.org/library/papers/23216872 | PubMed |
| 19 | 33301790 | Gastric emptying in health and type 2 diabetes: An evaluation using a 75 g oral glucose drink. | Diabetes Res Clin Pract | 2021 | https://conductscience.org/library/papers/33301790 | PubMed |
| 20 | 39201418 | Pathophysiological Relationship between Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Therapeutic Approaches. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201418 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALPP | 250 | PubTator's text mining | https://conductscience.org/library/genes/250 | NCBI Gene |
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| G6PC1 | 2538 | PubTator's text mining | https://conductscience.org/library/genes/2538 | NCBI Gene |
| GGT1 | 2678 | PubTator's text mining | https://conductscience.org/library/genes/2678 | NCBI Gene |
| GGTLC5P | 653590 | PubTator's text mining | https://conductscience.org/library/genes/653590 | NCBI Gene |
| GIP | 2695 | PubTator's text mining | https://conductscience.org/library/genes/2695 | NCBI Gene |
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41767367
GET https://conductscience.org/api/papers/v1/41767367/references?page=2